Table 1.
Patient characteristics.
| Patients with Melanoma and BM (n = 30) | |
|---|---|
| Median age at surgery (years) | 62 (43–84 1) |
| Female sex | 11 (37%) |
| Median GPA index | 2.5 (0.5–4.0) |
| Median preoperative KPS | 80 (50–100) |
| Previous oncological therapy 2 | 12 (40%) |
| Preoperative corticosteroid intake | 13 (43%) |
| Multiple BM | 4 (13%) |
| Admission median CRP (mg/L) | 12.3 (0.2–102.8) |
| Admission median WBC (g/L) | 12.9 (4.3–32.2) |
| Admission median neutrophils (g/L) | 8.4 (2.04–30.02) |
| Admission median lymphocytes (g/L) | 1.7 (0.25–3.26) |
| Admission median monocytes (g/L) | 0.79 (0.2–1.83) |
| Admission median platelets (g/L) | 306.8 (179–603) |
| Median OS (months) | 7 (95% CI 5.7–8.3) |
1 Range. 2 Chemo- and/or immunotherapy. BM, brain metastasis; CRP, C-reactive protein; KPS, Karnofsky performance status; WBC, white blood cells; GPA, Graded Prognostic Assessment; OS, overall survival; CI, confidence interval. Laboratory values are described as median and range.